Navigation Links
Pew Applauds Introduction of Preservation of Antibiotics for Medical Treatment Act

PAMTA would curtail the growth of resistant bacteria on factory farms

WASHINGTON, March 17 /PRNewswire-USNewswire/ -- Nearly one year after the Pew Commission on Industrial Farm Animal Production released its landmark recommendations on how America should reform the way food animals are raised, U.S. Representative Louise Slaughter today introduced the Preservation of Antibiotics for Medical Treatment Act of 2009 (PAMTA). The bill amends the Federal Food, Drug, and Cosmetic Act to withdraw the use of seven classes of antibiotics vitally important to human health from use on factory farms unless animals or herds are sick with disease.

"Human antibiotics are routinely misused on factory farms to promote faster animal growth and compensate for crowded, stressful and unsanitary conditions," said Robert Martin, a senior officer with the Pew Environment Group. "Medical experts agree that this practice directly contributes to a dramatic rise in antibiotic-resistant infections in people. We must reduce the use of antibiotics today to help preserve their effectiveness tomorrow."

According to estimates by the Union of Concerned Scientists, 50 million pounds of antibiotics have been used in industrial farm animal production since PAMTA was last introduced two years ago. Also during those two years, nearly one billion pounds of untreated livestock manure has been introduced into the environment. According to the United States Department of Agriculture, pathogens and pharmaceutically-active compounds in manure can be transmitted to other animals and humans through the foods we eat and water we drink. In addition, production of fresh fruit and vegetables using manure or irrigating with wastewater could be mechanisms of pathogen transfer. While human antibiotics are being used in enormous quantities on the farm, they are becoming less effective in people. At the same time, few new antibiotics are entering the market to take the place of ineffective ones. The Food and Drug Administration last approved a new antibiotic for humans in 2003.

The seven classes of drugs that would be revoked from routine use include penicillins, tetracyclines, macrolides, lincosamides, streptogramins, aminoglycosides, sulfonamides and any other drug used to treat bacterial illness in people.

"Doctors almost always warn their patients never to take antibiotics if they are not actually sick," said Laura Rogers, Project Director of the Pew Campaign on Human Health and Industrial Farming ( "Yet this is what is happening on industrial farms today--healthy animals are fed low doses of antibiotics over long periods of time, creating the ideal breeding ground for bacteria to become resistant. Our food production practices need to change in order to keep us all safe."


According to the Infectious Diseases Society of America, 90,000 people die each year of a hospital-acquired infectious disease. Of these individuals, an estimated 70 percent have infections that are resistant to at least one antibiotic drug. One study estimates that in 2005 MRSA (methicillin-resistant Staphylococcus aureus), a particularly severe bacterial infection that is resistant to antibiotics, caused over 18,000 deaths in the United States--a mortality level greater than that of HIV/AIDS. Such severe illnesses result in both higher frequency and longer duration of hospitalizations, raising the cost of health care. In 1998, the Institute of Medicine estimated that antibiotic-resistant bacteria generated an estimated $4 to 5 billion dollars per year in extra costs to the U.S. healthcare system, and it is likely these costs have increased over time.

Medical experts across the globe agree that the growth of bacterial infections resistant to antibiotic treatment is a looming public health crisis, and the misuse of antibiotics on industrial animal farms plays a significant role in that crisis. The Union of Concerned Scientists estimates that as much as 70 percent of all antibiotics sold in the U.S. are destined for food animal production, not to treat diagnosed diseases, but for weight gain and disease prevention in the crowded, unsanitary conditions of many factory farms. While antibiotics are prescribed in people for short-term disease treatment, these same critically important drugs--drugs like tetracycline, erythromycin and ciproflaxin--are fed to herds or flocks at low doses often over their entire lives, creating ideal conditions for the breeding of new and dangerous antibiotic-resistant bacteria.

Resistant bacteria can transfer drug resistance to other bacteria and enter the human population through not just eating but handling contaminated meat, through contact with farm workers, or through pollution of the local environment, air, or water supply. As a result, many serious infections--ranging from E. coli to pneumonia to malaria and anthrax--are increasingly difficult to treat with even the most potent antibiotics.

About the Campaign

Three years ago, The Pew Charitable Trusts launched an independent national commission to assess the farm animal industry's impact on public health, the environment, farm communities and animal health. In April, 2008, the Pew Commission on Industrial Farm Animal Production called for stricter regulation of antibiotic use in large-scale animal operations to preserve pharmaceutical efficacy for humans and to encourage more sanitary husbandry conditions. The Pew Health and Human Services Policy program and the Pew Environment Group have taken up that call, launching an effort to eliminate the routine use of life-saving antibiotics in healthy animals raised on factory farms. For more information, please visit us at

About Pew

The Pew Charitable Trusts ( is driven by the power of knowledge to solve today's most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public and stimulate civic life. We partner with a diverse range of donors, public and private organizations and concerned citizens who share our commitment to fact-based solutions and goal-driven investments to improve society.

SOURCE Pew Charitable Trusts
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. USP applauds nomination of Dr. Margaret Hamburg as FDA Commissioner
2. AstraZeneca Applauds Appointment of New FDA Commissioner
3. APS applauds Senate passage of FY09 omnibus bill
4. Religious Coalition for Reproductive Choice President Applauds Obama Stem Cell Policy
5. CAMR Applauds President Obamas Commitment to Embryonic Stem Cell Research
6. ASPS Applauds Introduction of Legislation to Increase Access to Reconstructive Surgery for Children
7. CPTA Applauds Legislation to Ease Patient Access to Physical Therapy Services
8. National Medical Association Applauds President Obama for Convening the White House Forum on Health Reform
9. Council for Quality Respiratory Care Applauds President Obamas Appointments of Governor Sebelius, DeParle to Lead Health Care Efforts
10. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Selection of Gov. Sebelius for Secretary of Health and Human Services
11. UPDATED: DGA Leadership Applauds Gov. Sebelius Cabinet Appointment
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing ... this disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely ... resulting in a way for homeless people to have a more dignified and ... new initiative whereby they are repurposing plastic bags into sleeping mats for the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since ... providing comprehensive solutions involving adult stem cell therapies to patients with chronic degenerative ... “Regenestem” name as a Registered Trademark (RTM). , Organizations are required to hold ...
(Date:11/24/2015)... (PRWEB) , ... November 25, 2015 , ... ... and monitoring. Their Care Plan software creates an agreement between the practice ... care plan, including financial, scheduling, monitoring, notification, and projections. Click here ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... and BERN, Switzerland , November ... ARTORG Center for Biomedical Engineering Research of the University ... Division of Endocrinology, Diabetes and Clinical Nutrition of the ... start of an exclusive collaboration to develop a novel ... for the personalised delivery of insulin for diabetic patients ...
(Date:11/24/2015)... FLINT, Mich. , Nov. 24, 2015 Diplomat ... , Senior Vice President of Clinical Services, Education and Human ... (AIS) online webinar, "Oral Oncology Drugs: Health Plan Strategies for ... co-presenting with Beckie Fenrick , a consultant with the ... The webinar will ...
(Date:11/24/2015)... 24, 2015 iRhythm Technologies, Inc. , a leading ... announced that it will participate in the 27th Annual Piper Jaffray ... New York, NY . Kevin King , Chief ... 1, 2015 at 8:50am ET. --> ... . --> . --> iRhythm is ...
Breaking Medicine Technology: